BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 16900224)

  • 1. Polymer conjugates as anticancer nanomedicines.
    Duncan R
    Nat Rev Cancer; 2006 Sep; 6(9):688-701. PubMed ID: 16900224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
    Gaspar R; Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1220-31. PubMed ID: 19682513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer therapeutics: concepts and applications.
    Haag R; Kratz F
    Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
    Taurin S; Nehoff H; Greish K
    J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dawning era of polymer therapeutics.
    Duncan R
    Nat Rev Drug Discov; 2003 May; 2(5):347-60. PubMed ID: 12750738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New possibilities of application of multifunctional polymers and polymer conjugates.
    Pluta J; Karolewicz B
    Acta Pol Pharm; 2003; 60(3):211-4. PubMed ID: 14556491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell uptake and trafficking behavior of non-covalent, coiled-coil based polymer-drug conjugates.
    Apostolovic B; Deacon SP; Duncan R; Klok HA
    Macromol Rapid Commun; 2011 Jan; 32(1):11-8. PubMed ID: 21432965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-drug conjugates: current status and future trends.
    Greco F; Vicent MJ
    Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.
    Battistella C; Klok HA
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28444959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.